C09K 11/88 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
H05B 33/14 - Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material
H05B 33/20 - Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the material in which the electroluminescent material is embedded
2.
FILTRATION SYSTEM AND AUTOMATED FILTRATION PROCESS FOR TESTING LIQUIDS USING CONSUMABLE FILTRATION UNITS
The present invention relates to hydroxyamino phosphinic acid derivatives of formula (I) in which the occurring groups and parameters have the meanings defined in claim 1, to a method for their preparation and to their use for the fabrication of self-assembled monolayers (SAM), in particular for the fabrication of switchable SAM for electronic devices. The invention further relates to electronic devices comprising said SAM, preferably in the field of organic electronics, in particular for use in memory, sensors, furthermore in organic light-emitting diodes (OLEDs), photovoltaics (OPVs), field-effect transistors (OFETs) and Josephson junctions, very particularly in memristive components such as memristive crossbar-arrays.
C07F 9/655 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
H10K 85/00 - Organic materials used in the body or electrodes of devices covered by this subclass
C07F 9/6553 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
4.
SILICON PRECURSOR COMPOUND IN ASYMMETRIC STRUCTURE, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING A SILICON-CONTAINING THIN FILM
The present invention relates to a silicon precursor compound in an asymmetric structure containing an alkoxide capable of preparing a silicon-containing thin film with high quality, to a method for preparing the same, and to a method for preparing a silicon-containing thin film using the silicon precursor compound in an asymmetric structure containing an alkoxide.
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
The present invention relates to a metal complex, a formulation comprising metal complex and a method for preparing a metal oxide optical layer using said formulation and metal complex. The obtained metal oxide optical layers are particularly suitable for applications in optical devices such as, for example, in augmented reality (AR) and/or virtual reality (VR) devices.
The invention relates to an optical component exhibiting a reverse or negative optical dispersion profile comprising two or more liquid crystalline polymer films, wherein the first utilized polymer film exhibits a uniform planar alignment of the polymerised LC molecules and the second polymer film adjacent to the first polymer film exhibits a cholesteric alignment of the polymerised LC molecules having a ¼ pitch rotation through the film thickness of the second polymer film. Furthermore, the present invention relates also to a method for its preparation. These optical components may be used for purposes suh as, for example, adjusting optical properties of a liquid crystal display (LCD), improving light utilization efficiency, or ensuring anti-reflectivity and visibility in an organic light emitting device (OLED), or even for AV/VR applications. Accordingly, the invention relates further to the use of such optical components for optical, electro-optical, decorative or security applications and to corresponding devices as such.
The present invention relates to nitrogen-containing heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
The present invention relates to nitrogen-containing compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
The invention relates to a method for producing indolo[3,2,1-jk]carbazole and derivatives by reacting a compound of formula (1) and at least one nitrosyl cation source.
The present invention relates to the use of polyvinyl alcohol for spray-drying to form an amorphous solid dispersion of an active pharmaceutical ingredient in a polyvinyl alcohol matrix. Furthermore, the invention relates to a process for producing an amorphous solid dispersion of an active pharmaceutical ingredient in a polyvinyl alcohol matrix by spray-drying.
The invention relates to a polymerizable LC material comprising one or more reactive mesogenic compounds and one or more compounds of formula (I), wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film obtainable from a corresponding polymerizable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerizable LC material in optical, electro-optical, in particular electrooptical devices in the field of augmented or virtual reality.
The disclosed and claimed subject matter provides precursors having at least one tethered cyclopentadienyl ligand ("Cp ligand"), at least one amidinate ligand ("Ad ligand") and a lanthanide and/or lanthanide-like transition metal ("M") of the general formulae (i) (Cp ligand)2-M-(Ad ligand) or (ii) (Cp ligand)-M-(Ad ligand)2.
The invention relates to a polymerizable LC material comprising one or more reactive mesogenic compounds and one or more compounds of formula I, (R12mnn I wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film obtainable from a corresponding polymerizable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerizable LC material in optical, electro-optical, decorative or security devices, in particular in optical or electrooptical devices in the field of augmented or virtual reality.
The invention relates to substituted bicycles of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
The application relates to the use of an antibody molecule that binds to MSLN and CD137 and a PD-1/PD-L1 inhibitor in the treatment of cancer in a patient.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
18.
CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND A CHEMOTHERAPEUTIC
The application relates to the use of an antibody molecule that binds to MSLN and CD137 and a chemotherapeutic in the treatment of cancer in a patient.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
G03F 7/027 - Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
G03F 7/038 - Macromolecular compounds which are rendered insoluble or differentially wettable
G03F 7/105 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers having substances, e.g. indicators, for forming visible images
G02B 1/00 - Optical elements characterised by the material of which they are made; Optical coatings for optical elements
G02F 1/00 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
C09D 4/06 - Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups
C08F 2/48 - Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
C09D 151/00 - Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
The present invention relates to effect pigments and multilayer films from two or more biodegradable polymer layers having different refraction indices and in alternating order, a method for producing them, and to their use, inter alia, in cosmetic products, rinse-off products, packaging materials, decorative films, paints, printing inks and plastics.
The present invention relates to a process for the preparation of a solid pharmaceutical administration form comprising an amorphous solid dispersion using a 3D printing process. The process is a printing process that allows the production of a solid pharmaceutical solid administration form comprising an amorphous solid dispersion in an easy and flexible manner and the possibility to achieve fast disintegrating dosage forms with high drug loads.
1111 are non-polar block copolymer segment comprising styrenic repeat unit, E', E'' E3and E42gg of about -5°C to about -50°C, and in structure (I) is multi-tethered with oligo flexible tethered groups at various positions as outlined. E'-A-L-B-E'' (I) E312111-E4 (III)
C08F 293/00 - Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
B82Y 40/00 - Manufacture or treatment of nanostructures
C08F 297/02 - Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer using a catalyst of the anionic type
C09D 153/00 - Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
H01L 21/00 - Processes or apparatus specially adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
The present invention relates to diazadibenzofuran derivatives and diazadibenzothiophene derivatives and to electronic devices containing said compounds, in particular organic electroluminescent devices containing said compounds in the form of triplet matrix materials, optionally combined with another triplet matrix material and suitable phosphorescent emitters, and to suitable mixtures and formulations.
3p4p3p3p3p3p4p4p cannot respectively, both simultaneously, be moieties of structure (IIIp) and (IVp), simultaneously be moieties of structure (IIIp) and (IVp1), or simultaneously be moieties of structure (IIIp) and (IVp2). The polymer of structure (A) must contain, one grafting end group moiety selected from structures (IIIp), (IVp), (IVp1) or (IVp2). Composition of this with a solvent are used in DSA processing.
C08F 4/08 - Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen of alkali metals
The present invention relates to diazadibenzofuran derivatives and diazadibenzothiophene derivatives and to electronic devices containing these compounds, in particular organic electroluminescent devices containing these compounds in the form of matrix materials, optionally in combination with a further matrix material and suitable phosphorescent emitters, and suitable mixtures and formulations of said compounds.
The present invention relates to novel compounds having valuable properties, in particular those which can be used for the preparation of medicaments as well as methods of their use and manufacture. Said compounds are particularly useful as PI4K inhibitors and for the treatment or prevention of PI4K-related disorders such as protozoan infections like malaria and virus infections.
The present invention relates to a heterocyclic compound of formula (1) as well as compositions and devices comprising these compounds, especially organic electroluminescent devices comprising these compounds as host materials.
The present invention relates to novel compounds having valuable properties, in particular those which can be used for the preparation of medicaments as well as methods of their use and manufacture. Said compounds are particularly useful as PI4K inhibitors and for the treatment or prevention of PI4K-related disorders such as protozoan infections like malaria and virus infections.
The present invention relates to liquid compositions comprising a nucleic acid having a reduced viscosity. Furthermore, the invention relates to methods for reducing the viscosity of a liquid compositions comprising a nucleic acid.
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
31.
NOVEL CRYSTALLINE FORMS OF (S)-7-OXA-2-AZA-SPIRO[4.5]DECANE-2-CARBOXYLIC ACID [7-(3,6-DIHYDRO-2H-PYRAN-4-YL)-4-METHOXY-THIAZOLO[4,5-C]PYRIDIN-2-YL]-AMIDE AND CO-CRYSTAL FORMS THEREOF
The invention relates to novel crystalline forms of (S)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(3,6-dihydro-2H-pyran-4-yl)-4-methoxy-thiazolo[4,5-c]pyridin-2- yl]-amide, processes for their preparation, medicaments and pharmaceutical preparations comprising these forms.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
A61K 31/4365 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
The invention relates to a method (100) for filling liquid crystal cells (40) with a medium (30) comprising at least one liquid crystalline material. The liquid crystal cells (40) comprise two substrates (42) joined together with a peripheral seal (44) so that a cavity (43) is formed, wherein the liquid crystal cells (40) comprise at least one fill opening (46). In a first step a) of the method (100) at least one liquid crystal cell (40) is placed (A) inside a vacuum chamber (12). In a subsequent step b) the vacuum chamber (12) is evacuated (B). After evacuation has been completed, the at least one fill opening (46) of the at least one liquid crystal cell (40) is contacted (C) with the medium (30) in a step c). In a subsequent step (D) the pressure in the vacuum chamber (12) is raised to an overpressure, wherein the rising pressure in the vacuum chamber (12) causes the medium (30) to fill (E) the cavity inside the at least one liquid crystal cell (40). Further aspects of the invention relate to an apparatus (10) for filling a liquid crystal cell (40) with a medium (30) comprising at least one liquid crystalline material, and to a computer readable medium (23) comprising a computer executable routine configured to perform at least one step of a method (100) according to the invention. The invention further relates to liquid crystal cells (40) obtainable by the method (100), in particular window elements for applications in buildings and vehicles with energy savings and improved comfort.
G02F 1/13 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
The present invention relates to a composition containing a light emitting moiety such as quantum materials incl. quantum dots; and a process for fabricating the composition.
A cap having a closed end and one or more openings is attached to the tip of an optical Raman probe sensor. The cap serves to block stray light noise from entering the tip of the sensor. In this way, Raman spectra may be more accurate and consistent. Further, the cap may be permanently affixed or removably attached to the sensor. In some embodiments, a reflective surface may be included on the interior surface of the closed end of the cap. This reflective surface may reflect Raman scattering light toward the tip, enhancing the received signal by a factor of 2 to 100.
The invention relates to a vehicle part (4) comprising a support part (6) which is made of a polymer material and which has a first surface (7) and a second surface (8) that is substantially parallel thereto; a first coating (9) which is applied onto the first surface (7) of the support part (6) and which has a first degree of reflection R1 for electromagnetic waves (5) of a specified frequency spectrum, in particular radar waves (5a, 5b); and a second coating (10) which is applied onto the second surface (8) of the support part (6) and which has a second degree of reflection R2 for electromagnetic waves (5) of the specified frequency spectrum. The second degree of reflection R2 matches the first degree of reflection R1 such that the support part (6), the first coating (9), and the second coating (10) form a resonator (11) for the electromagnetic waves (5). The invention additionally relates to a sensor assembly, to a motor vehicle, and to a method for improving the degree of transmission of a vehicle part.
G01S 7/02 - RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES - Details of systems according to groups , , of systems according to group
G01S 13/931 - Radar or analogous systems, specially adapted for specific applications for anti-collision purposes of land vehicles
H01Q 1/42 - Housings not intimately mechanically associated with radiating elements, e.g. radome
H01Q 1/44 - ANTENNAS, i.e. RADIO AERIALS - Details of, or arrangements associated with, antennas using equipment having another main function to serve additionally as an antenna
H01Q 1/32 - Adaptation for use in or on road or rail vehicles
The invention relates to a polymer composition containing a polyamide- or polyester-carrier polymer matrix into which special polymer particles are embedded, to a method for producing the polymer composition, to its use as a laser marking additive or laser welding additive in organic polymer compositions, and to a laser-markable or laser-weldable organic polymer composition containing the polymer composition.
The invention relates to a liquid-crystalline medium having a nematic phase comprising one or more compounds of formula (I) wherein the parameters have the meaning given in the text, and a negative dielectric component. It can be used in liquid-crystal electrooptical elements, particularly in liquid-crystal lenses. The mixtures have high optical anisotropy and high refractive index, simultaneously they are suitable for fast switching combined with low power consumption using a dual frequency addressing.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/18 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
38.
DEVELOPER TOLERANCE RESIST UNDERLAYER COMPOSITION AND METHOD FOR MANUFACTURING RESIST PATTERN
A developer tolerance resist underlayer composition comprising a polymer (A), a cross-linking agent (B), a thermal acid generator (C) and a solvent (D): wherein the polymer (A) comprises at least a unit having a protective group that is deprotected by an acid, and the hydrophilicity of the portion where the deprotected unit is present changes after exposure.
G03F 7/039 - Macromolecular compounds which are photodegradable, e.g. positive electron resists
G03F 7/09 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers
G03F 7/095 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers having more than one photosensitive layer
G03F 7/11 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers having cover layers or intermediate layers, e.g. subbing layers
39.
MACHINE-LEARNING ENHANCED PRODUCTION PROCESS WITH MULTI-TARGET MODELLING
A method and a system for improving a production process of a product via a computer wherein the computer runs a software performing a machine learning model which is used to predict target production process parameters based on specific input data of the production process and therefore trained with a specific training dataset regarding that input data and target parameters, and finally the predicted target parameters are used to improve the production process, wherein the machine learning model predicts at least two different target parameters at the same time and is therefore trained with a joint training data set adapted to the at least two target parameters.
The present invention relates to a compound of formula (I), to the use of the compound in an electronic device, to a method for producing said compound, and to an electronic device containing the compound.
The present invention relates to compounds that are suitable for use in electronic devices, and to electronic devices, more particularly organic electroluminescent devices, containing these compounds.
C23C 16/30 - Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof
C23C 16/448 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the method of coating characterised by the method used for generating reactive gas streams, e.g. by evaporation or sublimation of precursor materials
The present invention relates to compounds of a formula (I), to their use in electronic devices, to electronic devices containing at least one compound of formula (I), and to methods for producing compounds of formula (I).
The present disclosure generally relates to the use of polyvinyl alcohol (PVA) in additive manufacturing technologies and techniques. More specifically, the present disclosure relates to the use of PVA in a selective laser sintering (SLS) method to additively manufacture an object, in particular a pharmaceutical dosage form.
The present application relates to a sampling lid assembly for a particle monitoring system, preferably a microbiological gas (for example, air) sampler or airborne particle counter. The present application also relates to a particle monitoring system comprising such sampling lid assembly.
The present disclosure generally relates to the use of poloxamer in additive manufacturing technologies and techniques. More specifically, the present disclosure relates to the use of poloxamer in a selective laser sintering (SLS) method to additively manufacture an object, in particular a pharmaceutical dosage form.
[Problem] To provide a polysiloxane composition capable of being cured at a low temperature and having good storage stability [Means for Solution] A polysiloxane composition according to the present invention comprises (I) a polysiloxane having a certain structure, (II) an ionic liquid, (III) an acid, and (IV) a solvent.
The invention relates to compounds of the formula (I), to methods for producing compounds of the formula (I), to the use of compounds of the formula (I) in electronic devices, and to electronic devices containing a compound of the formula (I).
The present invention relates to: heterocycles that are suitable for use in electronic devices; and electronic devices, in particular photoelectric devices, containing these compounds.
The present invention relates to a composition comprising an electron-transporting host and a hole-transporting host, to the use thereof in electronic devices and to electronic devices containing said composition. The electron-transporting host corresponds to a compound of formula (1) from the class of N-bridged triphenylenes that contain a linker bonded via the N atom, to which a substituted pydridine, pyrimidine or triazine moiety is bonded.
The present invention relates to: organic heterocycles that are suitable for use in electronic devices; and to electronic devices, in particular photoelectric devices, containing these compounds.
The present invention relates to a composition comprising an electron-transporting host and a hole-transporting host, to the use thereof in electronic devices and to electronic devices containing said composition. The electron-transporting host corresponds to a compound of formula (1) from the class of N-bridged triphenylenes that contain a substituted pydridine, pyrimidine or triazine moiety bonded via the N atom.
The present disclosure relates to a novel treatment regimen for the treatment of autoimmune diseases and other inflammatory diseases with BTK (Bruton's tyrosine kinase) inhibitors. In particular, the present disclosure relates to a treatment that combines BTK inhibitor treatment with vaccination to avoid, reduce the risk of contracting or ameliorate an infection. Moreover, the present disclosure relates to vaccination in the presence of a BTK inhibitor.
The present invention relates to a method of printing a functional layer containing at least two different organic functional materials A and B comprising the following steps: (a) providing a substrate, having at least a first pixel type A, (b) printing a first ink A, containing at least one organic functional material A and at least one organic solvent A, into the first pixel type A, (c) printing a second ink B, containing at least one organic functional material B, which is different from the organic functional material A, and at least one organic solvent B, which is different from the organic solvent A, and which is miscible with organic solvent A in every mixing ratio at room temperature, into the first pixel type A, and (d) thereafter drying the first pixel type A, characterized in that - the organic functional material A has a solubility in the organic solvent A of ≥ 20 g/l at room temperature, - the organic functional material B has a solubility in the organic solvent B of ≥ 20 g/l at room temperature, and - the organic functional material A has a solubility in the organic solvent B of < 20 g/l at room temperature, as well as to a kit of inks.
H10K 71/13 - Deposition of organic active material using liquid deposition, e.g. spin coating using printing techniques, e.g. ink-jet printing or screen printing
H10K 71/15 - Deposition of organic active material using liquid deposition, e.g. spin coating characterised by the solvent used
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
56.
STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID AND NACL
The present invention is directed to solid pharmaceutical compositions comprising 5,10-methylene- (6R)-tetrahydrofolic acid and NaCl, as well as processes for obtaining the same, and the use of such products.
The present invention relates to stable formulations and lyophilizates comprising a high content of the disodium salt of 5,10-methylene-(6R)-tetrahydrofolic acid, sulfate and citrate.
The present invention relates to stable lyophilizates comprising a high content of 5,10- methylene-(6R)-tetrahydrofolic acid, which compositions do not contain any extraneous stabilizers or further chemotherapeutic agents.
C09D 4/06 - Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups
C09D 5/00 - Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
G02B 1/14 - Protective coatings, e.g. hard coatings
The present invention relates to liquid compositions comprising a high content of the sodium salt of 5,10-methylene-(6R)-tetrahydrofolic acid and sulfate, which formulations and lyophilizates do not contain any extraneous stabilizers.
The invention relates to a polymerisable LC medium comprising one or more di- or multireactive mesogenic compounds, one or more chiral compounds with (s)-configuration, one or more chiral compounds with (R)- configuration, wherein at least one of the chiral compounds comprises an photoisomerisable group. Furthermore, the present invention relates also to a method for its preparation, a polymer film obtainable from a corresponding polymerisable LC medium, to a method of preparation of such polymer film. These polymer films may be used for purposes such as, for example, adjusting optical properties of a liquid crystal display (LCD), improving light utilization efficiency, or ensuring anti-reflectivity and visibility in an organic light emitting device (OLED), or even for AV/VR. Accordingly, the invention relates further to the use of such polymer film and said polymerisable LC medium for optical, electro-optical, decorative or security applications and to corresponding devices as such.
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
G03F 7/027 - Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
G03F 7/033 - Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders the binders being polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. vinyl polymers
The new LC media exhibit a new spontaneous, self-supporting ferroelectric smectic phase. They typically comprise one or more dielectrical neutral, aromatic compounds described further in the description in a highly polar host mixture typical for ferroelectric nematic mixtures. The mixtures are useful for electro-optics, electronics, electro-mechanic and other applications for materials with very high dielectric permittivity. In addition, the present invention relates to liquid crystal devices, electric and electronic elements which contain the liquid crystalline media according to the invention.
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/18 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
The new LC media exhibit a ferroelectric nematic phase at ambient temperature. They comprise at least one or more compounds of formula (IA) having at least five rings, in which the variable groups have the meanings indicated in the text and in the claims. The mixtures are useful for electro-optics, electronics, electro-mechanic and other applications for materials with very high dielectric permittivity.
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
The present invention relates to boronic acid derivatives according to formula (I-a), (I-b), (I-c) or (1-d), or a pharmaceutically acceptable salt thereof. These compounds are useful for inhibiting the activity of immunoproteasome (LMP7) and for the treatment and/or prevention of medical conditions affected by immunoproteasome activity such as inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases and cancer.
G03F 7/11 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers having cover layers or intermediate layers, e.g. subbing layers
The present invention encompasses diphenyl urea selected but not limited from the group of compounds 1 -7 for use in the treatment of virus and coronavirus infections, including COVID-19, alone or in combination with one or more additional therapeutic agents.
A61K 31/435 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
The present invention relates to a process for preparing a deuterated organic compound, comprising the following steps: preparing a liquid composition comprising the organic compound, at least one heterogeneous metal catalyst, at least one deuterium source, and at least one aliphatic hetero compound, and optionally at least one aliphatic hydrocarbon, as a solvent.
C07B 59/00 - Introduction of isotopes of elements into organic compounds
C07D 209/52 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
C07D 251/04 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
C07C 15/38 - Polycyclic condensed hydrocarbons containing four rings
C07C 211/61 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
70.
SUBSTRATE COATING RESIST COMPOSITION AND METHOD FOR MANUFACTURING RESIST PATTERN
Provided is a substrate coating resist composition containing a polymer (A) having a specific structure and a photoacid generator (B) having a specific structure.
The present invention relates to an apparatus and a process for handling an equipment- tray assembly. The present invention in particular concerns the fields of bioburden testing, water testing, pharmaceutical, cosmetics, food processing, semiconductor production, electronics, and environmental monitoring of closed processing areas.
Tetrahydropyrido[3,4-d]pyrimidine compounds are provided that are potent HPK1 inhibitors. The compounds are useful to treat or prevent cancer and/or inflammatory and/or autoimmune diseases or symptoms thereof in mammals, particularly humans. The compounds have a chemical structure of the general Formula (I), (II), (III), (IV) or (V) or enantiomers or diastereomers or mixtures thereof or pharmaceutically acceptable salts thereof.
A61P 37/00 - Drugs for immunological or allergic disorders
A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
A61K 31/551 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
A61K 31/519 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
73.
EXCIPIENTS FOR PURIFICATION AND VIRUS FILTRATION OF BIOLOGICAL FLUIDS
Methods are disclosed for filtering a biological fluid that includes housing a surface treated porous membrane in a filtration device, optionally a virus filtration device, having an input and an output; introducing a biological fluid into the input of the filtration device wherein an aromatic excipient is added to the biological fluid; and collecting a filtrate from the output. In some embodiments, the biological fluid comprises a monoclonal antibody solution, a protein-containing solution, a solution containing fragment antigen-binding fragments, a solution containing recombinant proteins, or a fractionated plasma product.
B01D 67/00 - Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
B01D 71/40 - Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
A surface treatment for a membrane, having a cross-linkable diacrylate solution used to make the cross-linked coating comprises a solution of at least one of 2.4-3.4% Hydroxypropyl acrylate and 1.1-2.1% polyethylene glycol diacrylate; 2.5-3.5% Bisphenol A ethoxylate diacrylate; 3.0-4.0% Bisphenol A ethoxylate diacrylate and 1.5-2.5% Hydroxypropyl acrylate; 1.5-2.5% Hydroxypropyl acrylate and 2.0-3.0% Polyethylene glycol diacrylate; 0.25-2.5% 2-Hydroxy-3-phenoxypropyl acrylate and 2.0-5.0% Polyethylene glycol diacrylate; or 3.0-4.0% Bisphenol A ethoxylate diacrylate. A filtration device for use with biological fluid, having a membrane; and a cross-linked coating on the membrane to form a surface modification or treatment, wherein the cross-linked coating is formed from a coating solution comprising a cross-linkable diacrylate.
B01D 67/00 - Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
B01D 71/40 - Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
DEVELOPMENT OF NOVEL NEUTRAL MATS CONTAINING HYDROXYL MONOMERS TO IMPROVE SIARC SUBSTRATE COMPATIBILITY FOR DIRECTED SELF-ASSEMBLY OF DIBLOCK COPOLYMERS
122. Also described is a composition comprising said random copolymer of structure (A) and an organic spin casting solvent and the process of using said composition in directed self-assembly processing.
C09D 133/08 - Homopolymers or copolymers of acrylic acid esters
C09D 133/12 - Homopolymers or copolymers of methyl methacrylate
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
H01L 21/027 - Making masks on semiconductor bodies for further photolithographic processing, not provided for in group or
76.
CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
C07D 253/00 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group
C07D 247/00 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups
H01L 21/00 - Processes or apparatus specially adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
77.
SAMPLE PREPARATION METHOD FOR STRUCTURE ELUCIDATION WITH POROUS FRAMEWORKS
The invention provides a sample preparation method for providing a prepared sample (25), the sample preparation method comprising: a preparation stage comprising providing a sample holding part (3), wherein the sample holding part (3) comprises a collection chamber (100) having an interior space (101), wherein the interior space (101) hosts one or more single crystals of a porous framework (20); a loading stage comprising providing a solvent (10) comprising an analyte (5) to the one or more single crystals of the porous framework (20); and an evaporation stage comprising periodically exchanging an aliquot of evaporation gas (40) from the interior space (101); thereby providing the prepared sample (25).
The present invention relates to polymers which contain specially substituted triarylamine repeating units, to methods for the production thereof, and to the use thereof in electronic devices, especially in organic electroluminescent devices, so-called OLEDs (OLED = Organic Light Emitting Diodes). The present invention also relates to organic electroluminescent devices which contain said polymers
C08G 61/12 - Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
C08L 65/00 - Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Compositions of derivatives of such polymers
C09D 165/00 - Coating compositions based on macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Coating compositions based on derivatives of such polymers
The present invention relates to an LC medium comprising two or more polymerizable compounds one of which has a monocyclic group, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the PSA (polymer sustained alignment) or SA (self-aligning) mode, to an LC display of the PSA or SA mode comprising the LC medium, and to a process of manufacturing the LC display using the LC medium, especially an energy-saving LC display and energy- saving LC display production process.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
The present invention relates to a composition comprising a electron-transporting host material, a phosphorescent emitter as a sensitizer and a fluorescent emitter, as well as devices comprising these compositions, especially organic electroluminescent devices including an emission layer comprising these compositions.
A method of computer-based small particle measurement for drug formulation, in which digital microscopy images (6) of the small particles (10) used for the drug formulation are created by an image sensor (5) and provided to a computer (2) performing a measurement software (8), the software (8) is segmenting the small particles (10) in the digital microscopy images (6) and calculating properties of the small particels (10) according to specific parameter sets, wherein the software (8) samples different candidate parameter sets, applies them automatically for the segmentation and/or calculation process and shows the results via a display (4) to a user (1), wherein the user (1) picks the candidate parameter set with the best results, the software (8) establishes and trains an internal machine learning model (7) with this user feedback and applies the trained model (7) to reiterate the automatic segmentation and/or calculation and user feedback obtaining process until an optimal parameter set has been approved by the user (1).
The present invention relates to a liquid-crystal (LC) medium based on a mixture of polar compounds, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode, to an LC display of the vertically aligned mode comprising the LC medium, especially an energy-saving LC display and to a process of manufacturing the LC display.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
Probe holder for a bioreactor or other container or vessel, functioning as a base platform or stand to hold a sensor or probe, such as a Raman probe, in its an open position to be sterilized as part of an assembly including the sensor attached to a housing or container with an aseptic connector. The holder aids the user in positioning the sensor or probe at least partially within or in fluid communication with the interior of the bioreactor or vessel and holding and/or locking it in position during the use of the sensor or probe.
A method for manufacturing a silicon nitrogenous film on a substrate having a groove comprising the following steps: (a) applying a silicon nitrogenous composition on a substrate having a groove to form a composition layer; (b) irradiating the composition layer with light having a wavelength of 200 to 229 nm; and (c) heating the substrate in a non-oxidizing atmosphere, wherein the refractive index of the silicon nitrogenous film is 1.70 to 2.40 for the light having a wavelength of 633 nm.
The present invention relates to a liquid-crystal (LC) medium based on a mixture of polar compounds, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode, to an LC display of the vertically aligned mode comprising the LC medium, especially an energy-saving LC display and to a process of manufacturing the LC display.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
86.
POLYCATIONIC POLYMER OR COPOLYMER HAVING DIFFERENT CATION TYPES FOR SLURRIES IN CHEMICAL MECHANICAL PLANARIZATION
Synthesis of polycationic polymer or copolymer is disclosed. The polycationic polymer or copolymer are formed by at least one first cationic monomer and at least one second cationic monomer wherein the first cationic monomer and the second cationic monomer have different cationic groups; such as imidazolium group and non- imidazolium group. Chemical Mechanical Planarization (CMP) slurries comprise abrasives; activator; oxidizing agent; additive comprising polycationic polymer or copolymer; and water are also disclosed. The use of the synthesized polycationic polymer or copolymer in the CMP slurries reduces dishing and erosion in highly selective tungsten slurries.
C08F 226/06 - Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
C08F 230/02 - Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium, or a metal containing phosphorus
C09G 1/02 - Polishing compositions containing abrasives or grinding agents
The present invention relates to liquid-crystalline (LC) media having positive dielectric anisotropy and to liquid-crystal displays (LCDs) containing these media, especially to displays addressed by an active matrix and in particular to energy efficient LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability against UV radiation and elevated temperatures.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
The present invention relates to liquid-crystalline (LC) media having positive dielectric anisotropy and to liquid-crystal displays (LCDs) containing these media, especially to displays addressed by an active matrix and in particular to energy efficient LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability against UV radiation and elevated temperatures.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
The present invention relates to liquid-crystalline (LC) media having positive dielectric anisotropy and to liquid-crystal displays (LCDs) containing these media, especially to displays addressed by an active matrix and in particular to energy efficient LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability against UV radiation and elevated temperatures.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
Pyrido[3,2-d]pyrimidine compounds are provided that are potent HPK1 inhibitors that are useful to treat or prevent cancer and/or inflammatory and/or autoimmune diseases or symptoms thereof in mammals, particularly humans. The compounds disclosed herein have a chemical structure of the general formula (I) and (II) or a prodrug or pharmaceutically acceptable salt of any of the foregoing including mixtures thereof in all ratios.
P22-059 Br - 82 - 5 10 15 20 25 30 Abstract The present invention relates to a polyoxometalate compound with a polyoxometalate cluster comprising Group 5 elements, a formulation comprising said polyoxometalate compound and a method for preparing an optical metal oxide layer using said formulation and polyoxometalate compound. The obtained optical metal oxide layers are particularly suitable for applications in optical devices such as, for example, in augmented reality (AR) and/or virtual reality (VR) devices. [Figure 1]
C07F 9/00 - Compounds containing elements of Groups 5 or 15 of the Periodic System
C23C 16/18 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the deposition of metallic material from metallo-organic compounds
G02B 1/00 - Optical elements characterised by the material of which they are made; Optical coatings for optical elements
The invention relates to a colored solar cell or colored solar cell module comprising two or more transparent front cover layers each comprising an effect pigment of different color, and to a process for its preparation.
Sheath gas flow system (10) for a microscope (100), including an injector (20) and an extractor (30) configured to be mounted to said microscope about an observation zone (105) of the microscope, the injector (20) comprising a housing (21) having at least one sheath gas inlet (25) and an injector wall (22) comprising a plurality of sheath gas injector orifices (24) arranged around said observation zone when the sheath gas flow system is mounted to said microscope for injecting a sheath of gas around the observation zone (105), the extractor (30) comprising at least one gas outlet (35) and an extractor wall (32) comprising a plurality of sheath gas extraction orifices (34) for sucking in the sheath of gas.
The disclosed and claimed subject matter relates to metal (e.g., Cr, Mo and W) carbonyl complexes with phosphorus-based ligands having improved (i.e., higher) thermal stability and low melting points, compositions containing the compounds and methods of using the compounds as precursors for deposition of metal-containing films.
C07F 11/00 - Compounds containing elements of Groups 6 or 16 of the Periodic System
C23C 16/00 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes
H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof
95.
NEGATIVELY CHARGED SILICA PARTICLES, METHOD OF PRODUCING SUCH PARTICLES, COMPOSITIONS COMPRISING SUCH PARTICLES, AND A METHOD OF CHEMICAL-MECHANICAL POLISHING USING SUCH PARTICLES
The present application relates to negatively charged silica particles, to a method of producing such particles, and to compositions comprising such particles as well as to a method for chemical mechanical polishing.
The invention relates to a liquid-crystalline medium having a nematic phase comprising one or more compounds of formula (I) wherein the parameters have the meaning given in the text, to novel compounds under formula (I), the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect which is fast and energy-saving, to displays of this type which contain a liquid-crystalline medium of this type.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
97.
CHEMICAL MECHANICAL PLANARIZATION USING AMINO-POLYORGANOSILOXANE-COATED ABRASIVES
Chemical mechanical planarization (CMP) polishing compositions, methods and systems using a stable colloidal abrasive particle dispersion are provided. The abrasive particles in the dispersion are amino-polyorganosiloxane-coated abrasive particles. The amino-polyorganosiloxane-coated abrasive particles have an amino functional polyorganosiloxane shell having a thickness of 0.1 nm to 10 nm, or 0.5 to 5 nm. The amino-polyorganosiloxane-coated abrasive particles have low silanol density and positive charge at acidic low pH range.
PARTICLE MONITORING SYSTEM, PORTABLE MICROBIAL AIR SAMPLER, METHOD FOR MONITORING PARTICLES IN A SAMPLE FLUID AND METHOD FOR CALIBRATING/ADJUSTING A PARTICLE MONITORING SYSTEM
The present application relates to a particle monitoring system, to a portable microbial air sampler, to a method for monitoring particles in a sample fluid, such as gases and particularly compressed gases, and to a method for calibrating/adjusting a particle monitoring system.
A61K 35/12 - Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
B01D 15/16 - Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
B01D 15/38 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups , e.g. affinity, ligand exchange or chiral chromatography
C07K 14/47 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans from vertebrates from mammals
100.
METHODS AND COMPOSITIONS FOR PURIFYING ADENO ASSOCIATED VIRUS PARTICLES
B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
patents
